 Zhiying You
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 18 | 2025 | 612 | 1.880 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 10 | 2024 | 260 | 1.330 |
Why?
| | Acute Kidney Injury | 7 | 2023 | 809 | 0.690 |
Why?
| | Glomerular Filtration Rate | 13 | 2025 | 745 | 0.640 |
Why?
| | Endothelium, Vascular | 6 | 2021 | 926 | 0.600 |
Why?
| | Kidney Failure, Chronic | 6 | 2023 | 566 | 0.570 |
Why?
| | Vascular Stiffness | 5 | 2025 | 493 | 0.520 |
Why?
| | Cognition | 6 | 2025 | 1146 | 0.510 |
Why?
| | Kidney | 10 | 2022 | 1467 | 0.490 |
Why?
| | Uric Acid | 3 | 2021 | 163 | 0.440 |
Why?
| | Sodium Bicarbonate | 3 | 2025 | 45 | 0.430 |
Why?
| | Fibroblast Growth Factors | 4 | 2020 | 171 | 0.410 |
Why?
| | Cognitive Dysfunction | 4 | 2025 | 381 | 0.400 |
Why?
| | Kidney Diseases | 3 | 2022 | 407 | 0.370 |
Why?
| | Hypertension | 5 | 2021 | 1284 | 0.360 |
Why?
| | Acidosis | 2 | 2025 | 101 | 0.360 |
Why?
| | Blood Pressure | 5 | 2021 | 1774 | 0.350 |
Why?
| | Complement System Proteins | 4 | 2022 | 327 | 0.340 |
Why?
| | Blood Vessels | 2 | 2024 | 187 | 0.330 |
Why?
| | Complement Factor B | 2 | 2023 | 109 | 0.330 |
Why?
| | Cardiovascular Diseases | 4 | 2023 | 2104 | 0.320 |
Why?
| | Brachial Artery | 3 | 2020 | 201 | 0.310 |
Why?
| | Double-Blind Method | 10 | 2025 | 1981 | 0.310 |
Why?
| | Metformin | 2 | 2024 | 330 | 0.310 |
Why?
| | Biomarkers | 12 | 2025 | 4144 | 0.300 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 2 | 2018 | 14 | 0.290 |
Why?
| | Oxidative Stress | 3 | 2025 | 1314 | 0.290 |
Why?
| | Creatinine | 2 | 2020 | 499 | 0.280 |
Why?
| | Sodium | 2 | 2019 | 216 | 0.280 |
Why?
| | Vasodilation | 3 | 2020 | 496 | 0.270 |
Why?
| | Prospective Studies | 15 | 2023 | 7572 | 0.260 |
Why?
| | Endothelial Cells | 3 | 2021 | 778 | 0.260 |
Why?
| | Critical Illness | 3 | 2023 | 804 | 0.250 |
Why?
| | Middle Aged | 28 | 2025 | 33228 | 0.250 |
Why?
| | Phosphates | 2 | 2024 | 182 | 0.250 |
Why?
| | Aged | 24 | 2025 | 23794 | 0.240 |
Why?
| | Cerebrovascular Circulation | 2 | 2025 | 241 | 0.240 |
Why?
| | Male | 37 | 2025 | 67311 | 0.230 |
Why?
| | Kidney Transplantation | 4 | 2019 | 701 | 0.230 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 2 | 2024 | 42 | 0.220 |
Why?
| | Lanthanum | 1 | 2024 | 13 | 0.220 |
Why?
| | Humans | 52 | 2025 | 136765 | 0.220 |
Why?
| | Renal Dialysis | 2 | 2019 | 435 | 0.220 |
Why?
| | Bicarbonates | 2 | 2023 | 44 | 0.220 |
Why?
| | Female | 36 | 2025 | 72795 | 0.210 |
Why?
| | Kidney Tubules | 1 | 2024 | 117 | 0.210 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 128 | 0.210 |
Why?
| | Caloric Restriction | 1 | 2024 | 123 | 0.200 |
Why?
| | Pregnancy Complications | 2 | 2018 | 524 | 0.200 |
Why?
| | Ferric Compounds | 1 | 2022 | 56 | 0.190 |
Why?
| | Sucrose | 1 | 2022 | 110 | 0.190 |
Why?
| | Cardiovascular System | 1 | 2023 | 137 | 0.190 |
Why?
| | Complement Factor H | 1 | 2022 | 75 | 0.180 |
Why?
| | Complement Pathway, Classical | 1 | 2021 | 20 | 0.180 |
Why?
| | Nephrosis, Lipoid | 1 | 2021 | 10 | 0.180 |
Why?
| | Curcumin | 1 | 2021 | 29 | 0.180 |
Why?
| | Breathing Exercises | 1 | 2021 | 21 | 0.180 |
Why?
| | Respiratory Muscles | 1 | 2021 | 33 | 0.180 |
Why?
| | Inhalation | 1 | 2021 | 29 | 0.180 |
Why?
| | Nephrotic Syndrome | 1 | 2021 | 38 | 0.180 |
Why?
| | Carcinoma, Basal Cell | 1 | 2022 | 74 | 0.180 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2021 | 47 | 0.180 |
Why?
| | Cardiolipins | 1 | 2021 | 85 | 0.170 |
Why?
| | Kidney Glomerulus | 1 | 2021 | 114 | 0.170 |
Why?
| | Peritoneal Dialysis | 1 | 2022 | 97 | 0.170 |
Why?
| | Disease Progression | 7 | 2023 | 2750 | 0.170 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2021 | 106 | 0.170 |
Why?
| | Adult | 20 | 2024 | 37631 | 0.170 |
Why?
| | Allopurinol | 2 | 2018 | 63 | 0.170 |
Why?
| | Pilot Projects | 5 | 2025 | 1692 | 0.170 |
Why?
| | Immunoglobulin M | 1 | 2021 | 289 | 0.160 |
Why?
| | Bone Diseases | 1 | 2020 | 62 | 0.160 |
Why?
| | Lipocalins | 1 | 2019 | 36 | 0.160 |
Why?
| | Antigen-Antibody Complex | 1 | 2019 | 90 | 0.160 |
Why?
| | Complement C3d | 1 | 2019 | 67 | 0.160 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 443 | 0.160 |
Why?
| | Epitopes | 1 | 2021 | 480 | 0.160 |
Why?
| | Vascular System Injuries | 1 | 2019 | 71 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2021 | 243 | 0.150 |
Why?
| | Spironolactone | 1 | 2019 | 36 | 0.150 |
Why?
| | Renal Replacement Therapy | 1 | 2019 | 92 | 0.150 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2019 | 54 | 0.150 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2018 | 59 | 0.150 |
Why?
| | Gene Amplification | 1 | 2018 | 104 | 0.150 |
Why?
| | Complement Factor D | 1 | 2018 | 30 | 0.150 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 560 | 0.150 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 90 | 0.140 |
Why?
| | Regional Blood Flow | 1 | 2020 | 473 | 0.140 |
Why?
| | Fructose | 1 | 2018 | 112 | 0.140 |
Why?
| | Accidental Falls | 1 | 2020 | 193 | 0.140 |
Why?
| | Potassium, Dietary | 1 | 2018 | 12 | 0.140 |
Why?
| | Infant, Low Birth Weight | 1 | 2018 | 140 | 0.140 |
Why?
| | Pulse Wave Analysis | 3 | 2025 | 269 | 0.140 |
Why?
| | Infant Mortality | 1 | 2018 | 115 | 0.140 |
Why?
| | Sodium, Dietary | 1 | 2018 | 41 | 0.140 |
Why?
| | Antibodies | 1 | 2019 | 411 | 0.140 |
Why?
| | Hyponatremia | 1 | 2018 | 42 | 0.140 |
Why?
| | Propensity Score | 1 | 2019 | 289 | 0.140 |
Why?
| | Frailty | 1 | 2020 | 169 | 0.140 |
Why?
| | Diet | 1 | 2025 | 1274 | 0.140 |
Why?
| | Complement Activation | 4 | 2022 | 410 | 0.140 |
Why?
| | Cell-Derived Microparticles | 1 | 2018 | 71 | 0.140 |
Why?
| | Complement Pathway, Alternative | 1 | 2018 | 122 | 0.140 |
Why?
| | Death | 1 | 2018 | 119 | 0.130 |
Why?
| | Calcitriol | 1 | 2017 | 58 | 0.130 |
Why?
| | Cholecalciferol | 1 | 2017 | 60 | 0.130 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 242 | 0.130 |
Why?
| | Vascular Calcification | 1 | 2018 | 108 | 0.130 |
Why?
| | Thrombocytopenia | 1 | 2019 | 198 | 0.130 |
Why?
| | Contrast Media | 1 | 2019 | 462 | 0.130 |
Why?
| | Hyperuricemia | 1 | 2016 | 44 | 0.130 |
Why?
| | Pre-Eclampsia | 1 | 2018 | 189 | 0.130 |
Why?
| | Living Donors | 1 | 2018 | 295 | 0.130 |
Why?
| | Nitric Oxide | 1 | 2021 | 915 | 0.120 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 247 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 664 | 0.110 |
Why?
| | Peripheral Arterial Disease | 1 | 2021 | 473 | 0.110 |
Why?
| | Skin Neoplasms | 1 | 2022 | 852 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2022 | 1041 | 0.110 |
Why?
| | Glioma | 1 | 2018 | 395 | 0.110 |
Why?
| | Interleukin-1 | 1 | 2017 | 964 | 0.100 |
Why?
| | Longitudinal Studies | 5 | 2020 | 2829 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 559 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 2016 | 839 | 0.100 |
Why?
| | Risk Factors | 7 | 2022 | 10325 | 0.100 |
Why?
| | Follow-Up Studies | 6 | 2019 | 5106 | 0.100 |
Why?
| | Lipocalin-2 | 2 | 2024 | 79 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2021 | 3539 | 0.090 |
Why?
| | Time Factors | 5 | 2021 | 6808 | 0.090 |
Why?
| | Tooth Loss | 1 | 2011 | 27 | 0.090 |
Why?
| | Healthcare Disparities | 1 | 2017 | 649 | 0.090 |
Why?
| | Human Growth Hormone | 1 | 2011 | 45 | 0.090 |
Why?
| | Growth Disorders | 1 | 2011 | 86 | 0.080 |
Why?
| | Severity of Illness Index | 4 | 2020 | 2822 | 0.080 |
Why?
| | Vitamin D | 3 | 2018 | 397 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2017 | 977 | 0.080 |
Why?
| | Risk Assessment | 4 | 2021 | 3432 | 0.080 |
Why?
| | Liver | 1 | 2018 | 1940 | 0.080 |
Why?
| | Young Adult | 6 | 2023 | 13127 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2021 | 1462 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2018 | 1235 | 0.080 |
Why?
| | Cross-Sectional Studies | 5 | 2020 | 5423 | 0.070 |
Why?
| | Aged, 80 and over | 5 | 2025 | 7585 | 0.070 |
Why?
| | United States | 7 | 2024 | 14690 | 0.070 |
Why?
| | Geography | 1 | 2008 | 198 | 0.070 |
Why?
| | Nutritional Status | 2 | 2022 | 344 | 0.070 |
Why?
| | Parathyroid Hormone | 2 | 2018 | 108 | 0.070 |
Why?
| | Prognosis | 3 | 2021 | 4013 | 0.070 |
Why?
| | Phosphorus | 2 | 2022 | 97 | 0.070 |
Why?
| | Independent Living | 2 | 2018 | 105 | 0.070 |
Why?
| | Mice | 5 | 2022 | 17757 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2024 | 1022 | 0.060 |
Why?
| | Self Report | 1 | 2011 | 822 | 0.060 |
Why?
| | Brain | 1 | 2018 | 2664 | 0.060 |
Why?
| | Coronary Disease | 1 | 2008 | 384 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2019 | 513 | 0.060 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2025 | 45 | 0.060 |
Why?
| | Middle Cerebral Artery | 1 | 2025 | 53 | 0.060 |
Why?
| | Pregnancy Outcome | 2 | 2018 | 412 | 0.060 |
Why?
| | Health Status Disparities | 1 | 2008 | 283 | 0.060 |
Why?
| | Aspirin | 1 | 2008 | 387 | 0.060 |
Why?
| | Child | 5 | 2023 | 21819 | 0.060 |
Why?
| | Intensive Care Units | 2 | 2021 | 800 | 0.060 |
Why?
| | Chitinase-3-Like Protein 1 | 1 | 2024 | 19 | 0.060 |
Why?
| | Vegetables | 1 | 2025 | 156 | 0.060 |
Why?
| | Obesity | 1 | 2017 | 2982 | 0.050 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2008 | 462 | 0.050 |
Why?
| | Animals | 6 | 2022 | 36847 | 0.050 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2024 | 70 | 0.050 |
Why?
| | Chemokine CCL2 | 1 | 2024 | 115 | 0.050 |
Why?
| | Pravastatin | 1 | 2023 | 41 | 0.050 |
Why?
| | Stroke | 2 | 2011 | 1118 | 0.050 |
Why?
| | Incidence | 2 | 2021 | 2792 | 0.050 |
Why?
| | Sex Factors | 2 | 2020 | 2060 | 0.050 |
Why?
| | Plant Proteins | 1 | 2023 | 113 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2021 | 4191 | 0.050 |
Why?
| | Patched-1 Receptor | 1 | 2022 | 16 | 0.050 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 15 | 0.050 |
Why?
| | Hypoalbuminemia | 1 | 2022 | 30 | 0.050 |
Why?
| | Nutrition Surveys | 1 | 2023 | 266 | 0.050 |
Why?
| | Serum Albumin | 1 | 2022 | 150 | 0.050 |
Why?
| | Gonadal Steroid Hormones | 1 | 2022 | 140 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2021 | 10745 | 0.040 |
Why?
| | Antibody Specificity | 1 | 2021 | 189 | 0.040 |
Why?
| | Cohort Studies | 3 | 2018 | 5701 | 0.040 |
Why?
| | Drug Combinations | 1 | 2022 | 343 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2022 | 329 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 195 | 0.040 |
Why?
| | Prevalence | 2 | 2018 | 2710 | 0.040 |
Why?
| | Minerals | 1 | 2020 | 42 | 0.040 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2019 | 38 | 0.040 |
Why?
| | Acute-Phase Proteins | 1 | 2019 | 67 | 0.040 |
Why?
| | Lymphocytes | 1 | 2022 | 393 | 0.040 |
Why?
| | Matched-Pair Analysis | 1 | 2019 | 39 | 0.040 |
Why?
| | Ultraviolet Rays | 1 | 2022 | 390 | 0.040 |
Why?
| | Colorado | 2 | 2021 | 4515 | 0.040 |
Why?
| | Allografts | 1 | 2019 | 146 | 0.040 |
Why?
| | Monocytes | 1 | 2022 | 563 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 401 | 0.040 |
Why?
| | Complement C4a | 1 | 2018 | 9 | 0.040 |
Why?
| | Half-Life | 1 | 2018 | 164 | 0.040 |
Why?
| | Hepatocytes | 1 | 2019 | 220 | 0.040 |
Why?
| | Transplantation, Homologous | 1 | 2019 | 415 | 0.040 |
Why?
| | Biological Availability | 1 | 2018 | 148 | 0.040 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2019 | 187 | 0.040 |
Why?
| | Complement C5a | 1 | 2018 | 71 | 0.040 |
Why?
| | Complement Membrane Attack Complex | 1 | 2018 | 39 | 0.040 |
Why?
| | Clone Cells | 1 | 2018 | 266 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2023 | 759 | 0.040 |
Why?
| | Chromosome Aberrations | 1 | 2018 | 155 | 0.040 |
Why?
| | Area Under Curve | 1 | 2018 | 314 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2019 | 308 | 0.040 |
Why?
| | Fathers | 1 | 2018 | 50 | 0.030 |
Why?
| | Healthy Aging | 1 | 2018 | 35 | 0.030 |
Why?
| | Ligands | 1 | 2019 | 661 | 0.030 |
Why?
| | TRPP Cation Channels | 1 | 2018 | 84 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 951 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 455 | 0.030 |
Why?
| | ROC Curve | 1 | 2018 | 545 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 477 | 0.030 |
Why?
| | Congenital Abnormalities | 1 | 2017 | 88 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 889 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2018 | 6032 | 0.030 |
Why?
| | Administration, Oral | 1 | 2018 | 813 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 844 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2018 | 562 | 0.030 |
Why?
| | Body Mass Index | 2 | 2017 | 2375 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1124 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 21382 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1321 | 0.030 |
Why?
| | Graft Rejection | 1 | 2019 | 620 | 0.030 |
Why?
| | Neuroimaging | 1 | 2018 | 259 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3555 | 0.030 |
Why?
| | Waiting Lists | 1 | 2017 | 262 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2018 | 888 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2019 | 778 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2019 | 887 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2024 | 1283 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 6726 | 0.030 |
Why?
| | Autoimmunity | 1 | 2019 | 908 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2022 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2216 | 0.030 |
Why?
| | Glucose | 1 | 2018 | 1019 | 0.030 |
Why?
| | Premature Birth | 1 | 2017 | 331 | 0.030 |
Why?
| | Recovery of Function | 1 | 2017 | 652 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 621 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1963 | 0.030 |
Why?
| | Overweight | 1 | 2017 | 557 | 0.020 |
Why?
| | Genotype | 1 | 2018 | 1914 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3284 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3008 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1430 | 0.020 |
Why?
| | Autoantibodies | 1 | 2019 | 1496 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 752 | 0.020 |
Why?
| | Cytokines | 1 | 2019 | 2084 | 0.020 |
Why?
| | Proteomics | 1 | 2018 | 1109 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2020 | 15504 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2011 | 120 | 0.020 |
Why?
| | Income | 1 | 2011 | 202 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5639 | 0.020 |
Why?
| | Mental Recall | 1 | 2011 | 201 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4282 | 0.020 |
Why?
| | Social Class | 1 | 2011 | 281 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2011 | 408 | 0.020 |
Why?
| | Educational Status | 1 | 2011 | 470 | 0.020 |
Why?
| | Blood Glucose | 1 | 2018 | 2181 | 0.020 |
Why?
| | Learning | 1 | 2011 | 406 | 0.020 |
Why?
| | Infant | 1 | 2018 | 9395 | 0.010 |
Why?
| | Calcium | 1 | 2011 | 1197 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1620 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 1032 | 0.010 |
Why?
| | Depression | 1 | 2011 | 1396 | 0.010 |
Why?
|
|
You's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|